Deinove appoints business development director

Michael Krel will form industrial alliances with leading chemicals companies

Deinove, a French specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, has appointed Michael Krel to the newly created post of executive vice president, business development.

Krel was previously business development manager at Metabolic Explorer, a green chemistry company specialising in the development of fermentation processes for commodity chemicals.

Deinove chief executive Jacques Biton said Krel’s main role will be to form collaborations and licensing deals with biofuels and chemicals companies worldwide.

You may also like

Media
Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

The UK biotech's Doggybone DNA platform won the Innovation Catalyst category at CPHI Milan 2026, recognising its potential to support scalable DNA production for genetic medicines
Manufacturing
Xelia and Hisun sign strategic global multiple-API partnership

Xelia and Hisun sign strategic global multiple-API partnership

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Design & Build
Agilent expands Boulder facility with dedicated enzymatic ligation laboratory for oligonucleotide therapeutics

Agilent expands Boulder facility with dedicated enzymatic ligation laboratory for oligonucleotide therapeutics

The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approaches as oligonucleotide pipeline demand grows
Media
CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

The two-day programme addresses practical barriers to sustainable procurement, manufacturing and packaging — with hackathon-style sessions and cross-industry collaboration designed to move beyond targets into measurable operational action
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Lonza advances aseptic spray drying for high-dose biologics

Lonza advances aseptic spray drying for high-dose biologics

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new modalities
Subscribe now